Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression

Context:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycysti...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 98; no. 11; pp. E1835 - E1844
Main Authors Murri, Mora, Insenser, María, Fernández-Durán, Elena, San-Millán, José L., Escobar-Morreale, Héctor F.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.11.2013
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS).Objective:We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs.Design:This was a case-control study.Settings:The setting was an academic hospital.Participants:We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m2), and six subjects per group were obese (BMI ≥ 30 kg/m2).Interventions:Blood samples were collected early in the morning after a 12-hour fast.Main Outcome Measures:We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155.Results:Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations.Conclusions:The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
AbstractList MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS). We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs. This was a case-control study. The setting was an academic hospital. We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m(2)), and six subjects per group were obese (BMI ≥ 30 kg/m(2)). Blood samples were collected early in the morning after a 12-hour fast. We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155. Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations. The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
Context:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS).Objective:We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs.Design:This was a case-control study.Settings:The setting was an academic hospital.Participants:We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m2), and six subjects per group were obese (BMI greater than or equal to 30 kg/m2).Interventions:Blood samples were collected early in the morning after a 12-hour fast.Main Outcome Measures:We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155.Results:Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations.Conclusions:The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
CONTEXT:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS). OBJECTIVE:We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs. DESIGN:This was a case-control study. SETTINGS:The setting was an academic hospital. PARTICIPANTS:We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m), and six subjects per group were obese (BMI ≥ 30 kg/m). INTERVENTIONS:Blood samples were collected early in the morning after a 12-hour fast. MAIN OUTCOME MEASURES:We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155. RESULTS:Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations. CONCLUSIONS:The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS).CONTEXTMicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS).We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs.OBJECTIVEWe aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs.This was a case-control study.DESIGNThis was a case-control study.The setting was an academic hospital.SETTINGSThe setting was an academic hospital.We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m(2)), and six subjects per group were obese (BMI ≥ 30 kg/m(2)).PARTICIPANTSWe included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m(2)), and six subjects per group were obese (BMI ≥ 30 kg/m(2)).Blood samples were collected early in the morning after a 12-hour fast.INTERVENTIONSBlood samples were collected early in the morning after a 12-hour fast.We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155.MAIN OUTCOME MEASURESWe measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155.Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations.RESULTSObesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations.The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.CONCLUSIONSThe present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
Context:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS).Objective:We aimed to evaluate the effects of sex, sex hormones, and PCOS and their interactions with obesity on the expression in the circulation of these miRNAs.Design:This was a case-control study.Settings:The setting was an academic hospital.Participants:We included 12 control women, 12 patients with PCOS, and 12 men selected as to have similar body mass index (BMI) and age. Six subjects per group had normal weight (BMI < 25 kg/m2), and six subjects per group were obese (BMI ≥ 30 kg/m2).Interventions:Blood samples were collected early in the morning after a 12-hour fast.Main Outcome Measures:We measured whole blood expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155.Results:Obesity significantly reduced the expression of miRNA-21, miRNA-27b, and miRNA-103. However, there was a significant interaction between obesity and the group of subjects in the expression of miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 consisting of obesity reducing the expression of these miRNAs in control woman and men, but tending to increase their expression in women with PCOS. These differences paralleled those observed in serum T concentrations.Conclusions:The present results suggest that miRNAs that play an important role in metabolic and immune system processes are influenced by obesity and circulating androgen concentrations.
Author Fernández-Durán, Elena
Murri, Mora
Escobar-Morreale, Héctor F.
Insenser, María
San-Millán, José L.
AuthorAffiliation Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
AuthorAffiliation_xml – name: Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
Author_xml – sequence: 1
  givenname: Mora
  surname: Murri
  fullname: Murri, Mora
  email: moramurri@gmail.com
  organization: 1Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
– sequence: 2
  givenname: María
  surname: Insenser
  fullname: Insenser, María
  organization: 1Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
– sequence: 3
  givenname: Elena
  surname: Fernández-Durán
  fullname: Fernández-Durán, Elena
  organization: 1Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
– sequence: 4
  givenname: José L.
  surname: San-Millán
  fullname: San-Millán, José L.
  organization: 1Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
– sequence: 5
  givenname: Héctor F.
  surname: Escobar-Morreale
  fullname: Escobar-Morreale, Héctor F.
  email: hectorfrancisco.escobar@salud.madrid.org
  organization: 1Diabetes, Obesity, and Human Reproduction Research Group; Hospital Universitario Ramón y Cajal and Universidad de Alcalá; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS); and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), E-28034 Madrid, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24037889$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEUhoNU7LZ657UEvLDCTs3XTCaXZVlbobjFVfAuzGQSm3UmWZMZ2_kT_c1mnV0vCsUDIeeE5w0n580JOHLeaQBeY3SOCUYfNuqcIEwzQnD5DMywYHnGseBHYIYQwZng5PsxOIlxgxBmLKcvwDFhiPKyFDPwsDRGqz5Cb-CNb0c1xt4quPpdhRGuR9cE32l4drNYrd_P4VrfwysfutRBnMPKNXBV62j7EXoHFzaooa16637Azn75fJERPD9kvD6kGNFJui_zHC7vt0HHaL17CZ6bqo361X4_Bd8-Lr8urrLr1eWnxcV1ppjIecaLFKQkAglCc0q0FsjwhjYlKlmVc10YSo3BpEknptJUcFPneUGFqhuECnoKzqZ7t8H_GnTsZWej0m1bOe2HKFNXONGoKP-PMiYI55SShL59hG78EFx6iKS4SLPHQuBEvdlTQ93pRm6D7dK05cGUBMwnQAUfY9DmH4KR3HkuN0ruPJc7zxNOHuHK9skG7_pQ2fYpEZtEd77tdYg_2-FOB3mrq7a_lSgFK3iZ7QQYpypLq-BJ9m6S-WH7VFd_fyL9A74Ow_E
CitedBy_id crossref_primary_10_1371_journal_pone_0163756
crossref_primary_10_1093_advances_nmaa105
crossref_primary_10_1093_biolre_ioaa058
crossref_primary_10_3390_ijms22020938
crossref_primary_10_1016_j_gene_2019_04_082
crossref_primary_10_1002_mrd_23741
crossref_primary_10_1016_j_metabol_2018_01_011
crossref_primary_10_1007_s00404_017_4570_y
crossref_primary_10_3892_mmr_2019_10446
crossref_primary_10_1007_s43032_021_00516_3
crossref_primary_10_1016_j_ncrna_2024_01_002
crossref_primary_10_1089_dna_2019_4622
crossref_primary_10_1186_s40659_023_00441_6
crossref_primary_10_1002_oby_23342
crossref_primary_10_3109_10408363_2014_937522
crossref_primary_10_34172_jlms_2023_23
crossref_primary_10_1002_jat_3516
crossref_primary_10_1007_s11010_019_03678_6
crossref_primary_10_3389_fphys_2023_1279469
crossref_primary_10_1016_j_trsl_2022_07_007
crossref_primary_10_1016_j_clinbiochem_2018_09_001
crossref_primary_10_3892_mmr_2017_7270
crossref_primary_10_3390_genes5030684
crossref_primary_10_1038_s41598_019_52856_5
crossref_primary_10_1371_journal_pone_0300461
crossref_primary_10_1155_2019_9193236
crossref_primary_10_1016_j_gyobfe_2015_07_016
crossref_primary_10_1016_j_trre_2017_12_001
crossref_primary_10_1016_j_cll_2018_02_007
crossref_primary_10_1080_21655979_2022_2080366
crossref_primary_10_1111_jog_14707
crossref_primary_10_3389_fendo_2017_00378
crossref_primary_10_1007_s10815_020_01922_3
crossref_primary_10_1039_D0CC03858J
crossref_primary_10_1155_2021_2022938
crossref_primary_10_1080_13813455_2017_1396349
crossref_primary_10_3389_fendo_2022_918805
crossref_primary_10_1016_j_cbi_2016_06_008
crossref_primary_10_1016_j_biotno_2025_01_003
crossref_primary_10_1186_s13048_023_01141_1
crossref_primary_10_1177_2042018820934319
crossref_primary_10_1093_molehr_gaac024
crossref_primary_10_1186_s13048_020_0611_4
crossref_primary_10_1016_j_fertnstert_2016_04_013
crossref_primary_10_1016_j_repbio_2015_10_005
crossref_primary_10_3389_fendo_2023_1233484
crossref_primary_10_1210_jc_2017_02344
crossref_primary_10_2147_DMSO_S345758
crossref_primary_10_2174_0929867326666191003154548
crossref_primary_10_1071_RD16110
crossref_primary_10_1007_s00441_023_03747_9
crossref_primary_10_1007_s42000_020_00210_0
crossref_primary_10_1186_s13048_020_00686_9
crossref_primary_10_1007_s10815_020_02019_7
crossref_primary_10_1038_s41598_017_13250_1
crossref_primary_10_1007_s10815_018_1199_0
crossref_primary_10_3389_fmed_2019_00242
crossref_primary_10_1016_j_tem_2016_11_008
crossref_primary_10_3892_mmr_2019_10253
crossref_primary_10_1007_s43032_019_00086_5
crossref_primary_10_1080_21691401_2019_1699826
crossref_primary_10_3390_cells10123342
crossref_primary_10_1080_09513590_2018_1459548
crossref_primary_10_3390_jcm13071936
crossref_primary_10_3390_ijms25063205
crossref_primary_10_1093_humupd_dmu031
crossref_primary_10_1016_j_fertnstert_2019_01_026
crossref_primary_10_1016_j_yexmp_2020_104482
crossref_primary_10_1093_biolre_ioaa098
crossref_primary_10_1080_09513590_2020_1843620
crossref_primary_10_3390_biomedicines10081816
crossref_primary_10_1080_1354750X_2019_1606279
crossref_primary_10_1002_mnfr_201600943
crossref_primary_10_1097_RD9_0000000000000088
crossref_primary_10_1016_j_ando_2017_04_024
crossref_primary_10_1016_j_arteri_2015_04_002
crossref_primary_10_1016_j_numecd_2017_10_015
crossref_primary_10_1038_srep16890
crossref_primary_10_3389_fendo_2020_571357
crossref_primary_10_3390_ijms24043910
crossref_primary_10_1210_en_2017_00219
crossref_primary_10_1016_j_prp_2024_155709
crossref_primary_10_1016_j_cyto_2015_07_007
crossref_primary_10_3390_app15052772
crossref_primary_10_1186_s13048_016_0298_8
crossref_primary_10_3390_cells12070983
crossref_primary_10_1155_2021_5587412
crossref_primary_10_1007_s00441_020_03187_9
crossref_primary_10_1002_jcb_26531
crossref_primary_10_1186_s12958_020_00687_9
crossref_primary_10_1007_s43032_024_01753_y
crossref_primary_10_1080_09513590_2018_1428299
crossref_primary_10_1002_cbf_4053
crossref_primary_10_15171_bi_2016_12
crossref_primary_10_3390_ijms24031838
crossref_primary_10_3390_ncrna6010005
crossref_primary_10_3389_fendo_2019_00879
crossref_primary_10_1155_2015_589230
crossref_primary_10_1038_srep24976
crossref_primary_10_1016_j_fertnstert_2015_06_029
crossref_primary_10_3390_bios12070533
crossref_primary_10_1530_REP_16_0071
crossref_primary_10_1007_s11906_014_0500_6
crossref_primary_10_1007_s12020_016_0878_9
crossref_primary_10_1080_09513590_2018_1460341
crossref_primary_10_3389_fendo_2020_00206
crossref_primary_10_1186_s13048_015_0162_2
crossref_primary_10_1186_s12905_022_01912_w
crossref_primary_10_3897_folmed_66_e137396
crossref_primary_10_3389_bjbs_2021_10209
crossref_primary_10_1016_j_metop_2022_100206
crossref_primary_10_1016_j_mce_2015_01_030
crossref_primary_10_1016_j_soard_2014_02_046
crossref_primary_10_1159_000444677
crossref_primary_10_3233_THC_181510
crossref_primary_10_1016_j_lfs_2020_118174
crossref_primary_10_1016_j_tjog_2022_05_013
crossref_primary_10_3390_children6080089
crossref_primary_10_5468_ogs_23193
crossref_primary_10_1016_j_ydbio_2021_08_008
crossref_primary_10_7717_peerj_8640
crossref_primary_10_3109_14647273_2014_956811
crossref_primary_10_1089_dna_2015_3176
crossref_primary_10_3389_fphys_2020_00904
crossref_primary_10_1016_j_gyobfe_2014_07_014
ContentType Journal Article
Copyright Copyright © 2013 by The Endocrine Society 2013
Copyright © 2013 by The Endocrine Society
Copyright_xml – notice: Copyright © 2013 by The Endocrine Society 2013
– notice: Copyright © 2013 by The Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
7TS
DOI 10.1210/jc.2013-2218
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Physical Education Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
Physical Education Index
DatabaseTitleList MEDLINE
Nucleic Acids Abstracts

MEDLINE - Academic

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage E1844
ExternalDocumentID 24037889
10_1210_jc_2013_2218
00004678-201311000-00067
10.1210/jc.2013-2218
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
H~9
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
.GJ
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABDPE
ABUWG
ABXZS
ACFRR
ACVCV
ACZBC
ADMTO
ADNBA
ADZCM
AEMQT
AEOTA
AERZD
AFFNX
AFFQV
AFKRA
AFYAG
AGMDO
AGORE
AHGBF
AI.
AJBYB
AJDVS
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
IAO
IHR
INH
ITC
J5H
M1P
MBLQV
N4W
NU-
OBFPC
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
7T5
7TM
H94
K9.
7X8
7TS
ID FETCH-LOGICAL-c4957-7666628290923532ee90f7d3d8084a57e6f33ff12dd80fae397fb55639cbd0063
ISSN 0021-972X
1945-7197
IngestDate Fri Jul 11 10:46:31 EDT 2025
Thu Jul 10 18:25:47 EDT 2025
Mon Jun 30 12:42:47 EDT 2025
Mon Jul 21 05:56:36 EDT 2025
Tue Jul 01 00:50:03 EDT 2025
Thu Apr 24 23:00:51 EDT 2025
Fri May 16 03:44:20 EDT 2025
Fri Feb 07 10:35:30 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4957-7666628290923532ee90f7d3d8084a57e6f33ff12dd80fae397fb55639cbd0063
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 24037889
PQID 3164451991
PQPubID 2046206
ParticipantIDs proquest_miscellaneous_1551639068
proquest_miscellaneous_1449277332
proquest_journals_3164451991
pubmed_primary_24037889
crossref_primary_10_1210_jc_2013_2218
crossref_citationtrail_10_1210_jc_2013_2218
wolterskluwer_health_00004678-201311000-00067
oup_primary_10_1210_jc_2013-2218
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-November
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-November
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2013
Publisher Oxford University Press
Copyright by The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Copyright by The Endocrine Society
SSID ssj0014453
Score 2.4934976
Snippet Context:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b,...
CONTEXT:MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b,...
MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b,...
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage E1835
SubjectTerms Adult
Body mass index
Case-Control Studies
Diabetes mellitus
Female
Gene expression
Gene Expression - physiology
Gonadal Steroid Hormones - blood
Humans
Immune system
Male
Metabolic disorders
Metabolism
MicroRNAs
MicroRNAs - blood
MicroRNAs - genetics
miRNA
Obesity
Obesity - genetics
Obesity - metabolism
Ovaries
Polycystic ovary syndrome
Polycystic Ovary Syndrome - genetics
Polycystic Ovary Syndrome - metabolism
Post-transcription
Sex hormones
Young Adult
Title Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201311000-00067
https://www.ncbi.nlm.nih.gov/pubmed/24037889
https://www.proquest.com/docview/3164451991
https://www.proquest.com/docview/1449277332
https://www.proquest.com/docview/1551639068
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbKkBAIId4GhYGMBBKo9ZQ35-XjtHbaxtoh1kr7FuXFgUGXTE0LjB_B_-PfcBc7Tip1aPClSpxrYuWe2Hf23XOEvBY88WDasZgTGwlzgshkceZHzOSe4Wd-ZkRVjaXR2N2fOoen_LTT-d2KWlou4u3k59q8kv_RKrSBXjFL9h80q28KDXAM-oVf0DD8XkvHwyYY46KYXSaXSLrcK75hJFxNRYAm5Ifd4xNw-fF1luJH7zPYqTVFP66bF7I4AO4bJGfzpCrolX_qnZ99HO8wy0QxdezFzYlp2PUNVAPnWDBABtbmbasXsdiiqNDZmCJPCxi18oYH6lwsAJWzmtdQIkEmw4-KuZ5CDnBFvJRoG0Vyt3-gr-LaeNVk4gI5Gyzn6kzGsYlcS55EOcNsyNb1w6KUwQMqH0OtiJi2Sg1sBvHA4cwzZdzvtljTpkb-wG8j3GyN40MY6fjaGQZcZJxhkP0SnmxZavZYIfIeH4d706OjcDI8ndwgNy3wYLC4xuDgvd7gcpyKIFV3S-VkYEJV-94r1tJKBmbLEbpD7n4vMLai_FqlVrQMpMl9ck95NnRHwvQB6Yj8Ibk1UrEbj8gvhVZaZLRBK63QSmu00reI1Xd9CjilNU77FKBBFUppkdMWSmmN0j7VGK0PAaHyrxqftMHnYzLdG05295mqBsIScOI95oGj7Vb7_uCTcNsSIjAyL7VT3_CdiHvCzWw7y0wrhZYsEmBoZzHS3wVJnKIlvkk2cuj0U0KDyEImhYRHaewEiRMZnGee6fmO5UQW97ukV7_1MFFU-VixZRaiyww6Cr8kIeooRB11yRstfSEpYq6Qo6DAq0SYFNmqtRuqz7IMbdNFFkFw5Lrklb4MswBu7UW5KJYlOPBOADCzbesvMrgnbgeGC495IpGjO4OsnJ7vB13CVqAUymzssFpKALuWWRU_l6KjcL1n1-jRc3K7-Uq3yMZivhQvwJJfxC-rb-IPkF7lKQ
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+polycystic+ovary+syndrome+%28PCOS%29%2C+sex+hormones%2C+and+obesity+on+circulating+miRNA-21%2C+miRNA-27b%2C+miRNA-103%2C+and+miRNA-155+expression&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Murri%2C+Mora&rft.au=Insenser%2C+Mar%C3%ADa&rft.au=Fern%C3%A1ndez-Dur%C3%A1n%2C+Elena&rft.au=San-Mill%C3%A1n%2C+Jos%C3%A9+L&rft.date=2013-11-01&rft.issn=1945-7197&rft.eissn=1945-7197&rft.volume=98&rft.issue=11&rft.spage=E1835&rft_id=info:doi/10.1210%2Fjc.2013-2218&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon